Richardpruen (talk | contribs) (/* Regulations (not including taxes) added study on TPD) |
Richardpruen (talk | contribs) (Umbrella review protocol (review of systematic reviews) added) |
||
| Line 545: | Line 545: | ||
**Keywords | **Keywords | ||
**Other | **Other | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37561572/ e-Cigarette Use and the Cessation of Tobacco Cigarette Smoking: Protocol for an Umbrella Review.] === | |||
* O'Leary R, Polosa R. JMIR Res Protoc. 2023 Aug 10;12:e47711. doi: 10.2196/47711. PMID: 37561572 | |||
* A protocol for an umbrella review: a systematic review of systematic reviews of ENDS for smoking cessation: | |||
** Methods: The search will retrieve systematic reviews that include both clinical trials and experimental studies on the use of ENDS for smoking cessation. We will also include nonrandomized cohort studies that track ENDS use and the subsequent abstinence from smoking. | |||
** Results: A second-order meta-analysis will calculate the range and average of quit rates for ENDS. A vote counting of the direction of effect, based on quit rates, will be used to present the relative effectiveness of ENDS for smoking cessation compared to other cessation treatments (including no treatment)… A sensitivity analysis will examine the impact of the intensity of cessation treatment on quit rates… Reporting bias will be presented with a tabulation of bias indicators. Publication bias will be assessed. | |||
* Of course we have the excellent Cochrane systematic review [https://www.cochrane.org/CD010216/TOBACCO can-electronic-cigarettes-help-people-stop-smoking-and-do-they-have-any-unwanted-effects-when-used (here)], but there are also other systematic reviews on the topic that don’t necessarily align with the findings of the gold-standard Cochrane one. This umbrella review could be useful in adding another layer to the evidence base, especially since it will be assessing different types of bias. | |||
* This umbrella review also has a novel angle compared to other systematic reviews, because it will include nonrandomized studies as well. Since most randomized studies are done in the context of a medical approach to cessation, they are often (though not always) limited to the minority who actively want to quit smoking soon. While nonrandomized studies have their own limitations, one advantage is that they more often include people who use ENDS as an alternative consumer product rather than as a medical cessation aid, making these studies more relevant to the majority of people who smoke. | |||
* Definitely one to keep an eye on... | |||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37041075/ Vaping and socioeconomic inequalities in smoking cessation and relapse: a longitudinal analysis of the UK Household Longitudinal Study.] === | === 2023: [https://pubmed.ncbi.nlm.nih.gov/37041075/ Vaping and socioeconomic inequalities in smoking cessation and relapse: a longitudinal analysis of the UK Household Longitudinal Study.] === | ||
edits